LAVAL, Quebec, Jan. 15, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma (“Acasti” or the “Corporation”) (Nasdaq:ACST) (TSX.V:APO), a Neptune Technologies & Bioressources Inc. (“Neptune”) subsidiary, reports the highlights of its financial results for the third quarter, ended November 30, 2012.
